§ Federal grant opportunity · NHTSA-693JJ926R000024-FY26
Innovative Traffic Safety Enforcement (ITSE) Grant Program
Anoko A Zankli Grantor is accepting applications for Innovative Traffic Safety Enforcement (ITSE) Grant Program. The deadline is September 1, 2027 and the published award range is $500K – $20M.
Key facts
- Funder
- Anoko A Zankli Grantor
- Application deadline
- September 1, 2027
- Award range
- $500K – $20M
- Eligibility
- Eligibility criteria are published in the funding opportunity announcement.
- Geography
- United States
- Focus areas
- Other (see text field entitled "Explanation of Other Category of Funding Activity" for clarification)
- Opportunity number
- NHTSA-693JJ926R000024-FY26
Program overview
The primary intent of this of the ITSE Grant Program is to 1) develop innovative traffic safety enforcement programs that demonstrate effectiveness by reducing the number of motor vehicle crashes due to one or more of the subject risky driving behaviors; and 2) ensure the traffic safety enforcement programs are repeatable and scalable for use by law enforcement throughout the United States. In addition to those goals, the Department seeks to fund projects that advance the priorities of this Administration as described in DOT’s mission statement and across executive orders.
How to apply
- Confirm your organization meets the eligibility criteria above.
- Read the full funding opportunity announcement from Anoko A Zankli Grantor.
- Draft your narrative against the funder's stated priorities and review criteria.
- Submit before September 1, 2027, allowing time for registration and validation.
Related grant opportunities
- Advancement and Innovation in Measurement of Language Development and Predictors (R01 Clinical Trial Not Allowed)
- Advancement and Innovation in Measurement of Language Development and Predictors (R21 Clinical Trial Not Allowed)
- Bioengineering Partnerships with Industry (U01 Clinical Trial Optional)
- Investigator Initiated Innovation in Computational Genomics and Data Science (R01 Clinical Trial Not Allowed)
- Investigator Initiated Innovation in Computational Genomics and Data Science (R21 Clinical Trial Not Allowed)
Find every grant your organization qualifies for
Mavenly scores this opportunity against your mission, geography, and funding history — then drafts the proposal with you and tracks the deadline through submission and reporting.